Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated about 6 hours ago
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
about 6 hours ago
AI drug discovery company Owkin has signed a pact with French drugmaker...
As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
about 6 hours ago
As the FDA marches toward the likely first approval of a psychedelic...
Lilly cans early experimental obesity drug after ‘high bar’ not met
about 14 hours ago
Eli Lilly has put the kibosh on an early-stage obesity drug after...
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
about 16 hours ago
Corbus Pharmaceuticals’ phase 1b obesity trial has generated evidence its CB1 inverse...
Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
about 16 hours ago
Electra Therapeutics is hoping to raise up to $341.9 million from an...
J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
about 18 hours ago
Johnson & Johnson is nearing a $20 billion deal to sell off...
No more Nordisk as Novo goes it alone amid rebranding push
about 19 hours ago
As Novo Nordisk continues its epic battle with Eli Lilly for market...
Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win
about 20 hours ago
Definium Therapeutics has scored a third straight phase 3 win for its...
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
about 20 hours ago
Cellectis may have kicked off the year promising “huge momentum” in the...
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
about 21 hours ago
MediLink has reported phase 3 results on a Roche-partnered antibody-drug conjugate. The...
BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readout
about 22 hours ago
BioNTech has linked gotistobart to median overall survival of 18.5 months in...
Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
1 day ago
Cullinan Therapeutics and Taiho Oncology unveiled phase 3 data showing survival improvements...